 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Sodium N-[10-(2-hydroxybenzoyl)amino] decanoate

Sodium N-[10-(2-hydroxybenzoyl)amino] decanoate

COA

Unit Price: Get Latest Price 

CAS No.:

264602-55-3

Grade:

Chemical Grade

Content:

99%

Port:

北京市

Packaging:

25kg/Cardboard drum

Price valid (until):

2026-01-24

Contact Supplier

 Chat Now

Beijing Ruqueen Biotech., Co., Ltd.

Company Type:

Trader

Location:

China

Qualification:

Main Products:

Calcium L-5-Methyltetrahydrofolate,Glucosamine L-5-methyltetrahydrofolate,Vadadustat,Temozolomide,4-Amino-5-imidazole carboxamide hydrochloride,Salcaprozate sodium

 Visit Store

Product Description
Seller Information

Description

Product Detail

Pls input...

Items	Specifications
Appearances	White to pale yellow or slightly pink ish powder
Related substances	Any impurity≤0.5%, Total impurities≤1.0%
Content	C ₁₇ H ₂₄ NNaO _{4 (anhydrous substance):} 98.0% to 102.0%

Certificates

Basic Info

Product Name:

10-((2-Hydroxybenzoyl)amino)decanoate sodium

Other Name:

PDQ2FCX8UK;UNII-PDQ2FCX8UK;Snad;SCHEMBL253212;10-((2-Hydroxybenzoyl)amino)decanoate sodium;Decanoic acid, 10-((2-hydroxybenzoyl)amino)-, sodium salt (1:1);264602-55-3

CAS No.:

264602-55-3

Molecular Formula:

C17H24NNaO4

InChIKeys:

XUHVCHNJCBBXMP-UHFFFAOYSA-M

Exact Mass:

329.16030253

UNII:

PDQ2FCX8UK

Categories:

Bulk Drug Intermediates

Characteristics

Seller Information

Business Type:
Trader

Main Products:
Calcium L-5-Methyltetrahydrofolate,Glucosamine L-5-methyltetrahydrofolate,Vadadustat,Temozolomide,4-Amino-5-imidazole carboxamide hydrochloride,Salcaprozate sodium

Location:
Room 101-602, 6th Floor, Building 15, No. 8 Yard, Liangshuihe 2nd Street, BDA, Beijing, China

Payment Terms:
L/C,100% TT in advance

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
11-50

Year of Establishment:
2017

Beijing Ruqueen Biotech.， Co., Ltd. is a high-tech enterprise integrating the R&D and business promotion of novel food ingredients, API s and intermediates, and novel pharmaceutical excipients. The company advocates a green, eco-friendly, and differentiated approach to health and wellness, emphasizing RSM ( Regulatory Starting Material ) research and QbD (Quality by Design) process development to ensure economical, environmentally friendly, safe, and quality-controllable manufacturing processes.

The company operates a 1,000+ square meter R&D center in the Beijing Economic-Technological Development Area (BDA), housing departments for process development, pilot-scale conversion, commercial production, quality research, and business promotion.

The center's team comprises Ph.D. and M.S. holders in chemistry with over 20 years of commercial production experience in APIs. It is equipped with multiple advanced instruments including: 50/100L glass reactors , 20L rotary evaporators , HPLC , IR , LC-MS , GC-MS . Additionally , the company maintains stable cooperative manufacturing bases in Tianjin City , Hebei Province , Shandong Province , Inner Mongolia Autonomous Region, and other regions, enabling scaled commercial production.

The company conducts R&D and commercial manufacturing of: Complex active pharmaceutical ingredients (APIs) , Pharmaceutical intermediates , Novel food ingredients and Advanced pharmaceutical excipients

The company provides comprehensive services including:
✓ Registration filing support for APIs/excipients (e.g., DMF/CEP preparation)
✓ Process optimization for existing pharmaceutical materials
✓ Enabling "API + Formulation" integration strategies for pharmaceutical partners

Intellectual Property Achievements:
✓ 3 authorized invention patents
✓ 8 pending patent applications (including 2 PCT international filings)
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

Sodium N-[10-(2-hydroxybenzoyl)amino] decanoate

Product Description

Seller Information

Related Searches